Trial Profile
Risk of Skin Cancer and Lymphoma in Users of Topical Tacrolimus, Pimecrolimus, and Corticosteroids
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Nov 2016
Price :
$35
*
At a glance
- Drugs Pimecrolimus (Primary) ; Tacrolimus (Primary) ; Corticosteroids
- Indications Atopic dermatitis
- Focus Adverse reactions
- Acronyms JOELLE
- Sponsors Astellas Pharma
- 10 Nov 2016 New trial record
- 02 Nov 2016 Results (n=227359) accessing utilization of Topical Tacrolimus and Pimecrolimus in Europe were presented at the 19th Annual European Congress of the International Society for Pharmacoeconomics and Outcomes Research
- 01 Mar 2013 Status changed from not yet recruiting to recruiting.